These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 35583650)

  • 1. Toxicological Aspects of Iron Oxide Nanoparticles.
    Fernández-Bertólez N; Costa C; Brandão F; Teixeira JP; Pásaro E; Valdiglesias V; Laffon B
    Adv Exp Med Biol; 2022; 1357():303-350. PubMed ID: 35583650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances on surface engineering of magnetic iron oxide nanoparticles and their biomedical applications.
    Gupta AK; Naregalkar RR; Vaidya VD; Gupta M
    Nanomedicine (Lond); 2007 Feb; 2(1):23-39. PubMed ID: 17716188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic iron oxide nanoparticles for tumor-targeted therapy.
    Chen B; Wu W; Wang X
    Curr Cancer Drug Targets; 2011 Feb; 11(2):184-9. PubMed ID: 21158723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic iron oxide nanoparticles as drug carriers: preparation, conjugation and delivery.
    El-Boubbou K
    Nanomedicine (Lond); 2018 Apr; 13(8):929-952. PubMed ID: 29546817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical synthesis and assembly of uniformly sized iron oxide nanoparticles for medical applications.
    Ling D; Lee N; Hyeon T
    Acc Chem Res; 2015 May; 48(5):1276-85. PubMed ID: 25922976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic iron oxide nanoparticles for drug delivery: applications and characteristics.
    Vangijzegem T; Stanicki D; Laurent S
    Expert Opin Drug Deliv; 2019 Jan; 16(1):69-78. PubMed ID: 30496697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications.
    Dadfar SM; Roemhild K; Drude NI; von Stillfried S; Knüchel R; Kiessling F; Lammers T
    Adv Drug Deliv Rev; 2019 Jan; 138():302-325. PubMed ID: 30639256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic drug delivery and targeting: principles and applications.
    Babincova M; Babinec P
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2009 Dec; 153(4):243-50. PubMed ID: 20208962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are iron oxide nanoparticles safe? Current knowledge and future perspectives.
    Valdiglesias V; Fernández-Bertólez N; Kiliç G; Costa C; Costa S; Fraga S; Bessa MJ; Pásaro E; Teixeira JP; Laffon B
    J Trace Elem Med Biol; 2016 Dec; 38():53-63. PubMed ID: 27056797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoparticle architecture preserves magnetic properties during coating to enable robust multi-modal functionality.
    Woodard LE; Dennis CL; Borchers JA; Attaluri A; Velarde E; Dawidczyk C; Searson PC; Pomper MG; Ivkov R
    Sci Rep; 2018 Aug; 8(1):12706. PubMed ID: 30139940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic nanoparticles for precision oncology: theranostic magnetic iron oxide nanoparticles for image-guided and targeted cancer therapy.
    Zhu L; Zhou Z; Mao H; Yang L
    Nanomedicine (Lond); 2017 Jan; 12(1):73-87. PubMed ID: 27876448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Applications and potential toxicity of magnetic iron oxide nanoparticles.
    Liu G; Gao J; Ai H; Chen X
    Small; 2013 May; 9(9-10):1533-45. PubMed ID: 23019129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicity of iron oxide nanoparticles: Size and coating effects.
    Abakumov MA; Semkina AS; Skorikov AS; Vishnevskiy DA; Ivanova AV; Mironova E; Davydova GA; Majouga AG; Chekhonin VP
    J Biochem Mol Toxicol; 2018 Dec; 32(12):e22225. PubMed ID: 30290022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron oxide nanoparticles for targeted cancer imaging and diagnostics.
    Rosen JE; Chan L; Shieh DB; Gu FX
    Nanomedicine; 2012 Apr; 8(3):275-90. PubMed ID: 21930108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxicity of iron oxide nanoparticles made from the thermal decomposition of organometallics and aqueous phase transfer with Pluronic F127.
    Gonzales M; Mitsumori LM; Kushleika JV; Rosenfeld ME; Krishnan KM
    Contrast Media Mol Imaging; 2010; 5(5):286-93. PubMed ID: 20623517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remote magnetic targeting of iron oxide nanoparticles for cardiovascular diagnosis and therapeutic drug delivery: where are we now?
    Bietenbeck M; Florian A; Faber C; Sechtem U; Yilmaz A
    Int J Nanomedicine; 2016; 11():3191-203. PubMed ID: 27486321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicity assessment of superparamagnetic iron oxide nanoparticles in different tissues.
    Vakili-Ghartavol R; Momtazi-Borojeni AA; Vakili-Ghartavol Z; Aiyelabegan HT; Jaafari MR; Rezayat SM; Arbabi Bidgoli S
    Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):443-451. PubMed ID: 32024389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetofluorescent nanohybrid comprising polyglycerol grafted carbon dots and iron oxides: Colloidal synthesis and applications in cellular imaging and magnetically enhanced drug delivery.
    Wen Y; Xu M; Liu X; Jin X; Kang J; Xu D; Sang H; Gao P; Chen X; Zhao L
    Colloids Surf B Biointerfaces; 2019 Jan; 173():842-850. PubMed ID: 30551300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomedical Applications of Advanced Multifunctional Magnetic Nanoparticles.
    Long NV; Yang Y; Teranishi T; Thi CM; Cao Y; Nogami M
    J Nanosci Nanotechnol; 2015 Dec; 15(12):10091-107. PubMed ID: 26682455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing cytotoxicity of (iron oxide-based) nanoparticles: an overview of different methods exemplified with cationic magnetoliposomes.
    Soenen SJ; De Cuyper M
    Contrast Media Mol Imaging; 2009; 4(5):207-19. PubMed ID: 19810053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.